Glaucoma News and Research

RSS
While there are many causes of glaucoma, most cases are associated with increased intraocular pressure. Loss of vision is usually characterized by a gradual reduction in peripheral vision, which can lead to a tunnel vision effect. Glaucoma affects approximately 100 million people globally and is one of the leading causes of blindness in the world today. An estimated three million Americans have this sight-threatening disease. Because it is painless and advances gradually, many people who have glaucoma or elevated IOP have not been diagnosed. If detected and treated early, vision can usually be preserved.
UAB professor receives $1.5 million grant to explore links between circadian fluctuations and glaucoma

UAB professor receives $1.5 million grant to explore links between circadian fluctuations and glaucoma

Electrical stimulation of the brain may help preserve visual neurons from cell death after injury

Electrical stimulation of the brain may help preserve visual neurons from cell death after injury

Study: Systemic therapy preserves vision of uveitis patients better than intraocular implant

Study: Systemic therapy preserves vision of uveitis patients better than intraocular implant

Scientists show ability to grow specific neurons for treatment of optic neurodegenerative diseases

Scientists show ability to grow specific neurons for treatment of optic neurodegenerative diseases

Newly-developed smart contact lens sensor may help diagnose diabetes and glaucoma

Newly-developed smart contact lens sensor may help diagnose diabetes and glaucoma

Researchers identify biomarker that could predict disease severity in glaucoma patients

Researchers identify biomarker that could predict disease severity in glaucoma patients

Research reveals 9.8 million Brits risk losing their sight after shunning eye tests

Research reveals 9.8 million Brits risk losing their sight after shunning eye tests

Infantile spasms and multiple sclerosis relapse data presented at AAN

Infantile spasms and multiple sclerosis relapse data presented at AAN

ARVO 2017 to showcase latest advances in treatments for eye disease and blindness

ARVO 2017 to showcase latest advances in treatments for eye disease and blindness

Powerful pain medicine may help reduce vision damage of glaucoma

Powerful pain medicine may help reduce vision damage of glaucoma

Healthy Vision Month: NEI focuses on women’s eye health

Healthy Vision Month: NEI focuses on women’s eye health

Simple eye test can diagnose early signs of glaucoma

Simple eye test can diagnose early signs of glaucoma

Glaucoma research can help make treatment more accessible in developing countries

Glaucoma research can help make treatment more accessible in developing countries

New report outlines strategies for regenerating retinal ganglion cells

New report outlines strategies for regenerating retinal ganglion cells

Dedicated staff contribute greatly to successful screening of diabetic retinopathy

Dedicated staff contribute greatly to successful screening of diabetic retinopathy

Clinical research trial investigates new treatment approach for early-stage eye melanoma

Clinical research trial investigates new treatment approach for early-stage eye melanoma

Discovery about retinal zinc may show new way to protect, regenerate optic nerve in glaucoma patients

Discovery about retinal zinc may show new way to protect, regenerate optic nerve in glaucoma patients

New portable camera can photograph the retina without need for pupil-dilating eye drops

New portable camera can photograph the retina without need for pupil-dilating eye drops

New micro-pump technology may offer promising alternative to eye drops for glaucoma patients

New micro-pump technology may offer promising alternative to eye drops for glaucoma patients

Optegra Eye Health Care’s flagship Central London hospital celebrates first anniversary

Optegra Eye Health Care’s flagship Central London hospital celebrates first anniversary